CoChat

Characterization of the Genomic and Immunologic Diversity of Malignant Brain Tumors through Multisector Analysis

Open access
Schaettler, Maximilian O., Richters, Megan M., Wang, Anthony Z., Skidmore, Zachary L., Fisk, Bryan, Miller, Katherine E., Vickery, Tammi L., Kim, Albert H., Chicoine, Michael R., Osbun, Joshua W., Leuthardt, Eric C., Dowling, Joshua L., Zipfel, Gregory J., Dacey, Ralph G., Lu, Hsiang-Chih, Johanns, Tanner M., Griffith, Obi L., Mardis, Elaine R., Griffith, Malachi, Dunn, Gavin P. · 2022 · Cancer Discovery
Cited by 69

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Despite some success in secondary brain metastases, targeted or immune-based therapies have shown limited efficacy against primary brain malignancies such as glioblastoma (GBM). Although the intratumoral heterogeneity of GBM is implicated in treatment resistance, it remains unclear whether this diversity is observed within brain metastases and to what extent cancer cell–intrinsic heterogeneity sculpts the local immune microenvironment. Here, we profiled the immunogenomic state of 93 spatially distinct regions from 30 malignant brain tumors through whole-exome, RNA, and T-cell receptor sequencing. Our analyses identified differences between primary and secondary malignancies, with gliomas displaying more spatial heterogeneity at the genomic and neoantigen levels. In addition, this spatial diversity was recapitulated in the distribution of T-cell clones in which some gliomas harbored highly expanded but spatially restricted clonotypes. This study defines the immunogenomic landscape across a cohort of malignant brain tumors and contains implications for the design of targeted and immune-based therapies against intracranial malignancies. Significance: This study describes the impact of spatial heterogeneity on genomic and immunologic characteristics of gliomas and brain metastases. The results suggest that gliomas harbor significantly greater intratumoral heterogeneity of genomic alterations, neoantigens, and T-cell clones than brain metastases, indicating the importance of multisector analysis for clinical or translational studies. This article is highlighted in the In This Issue feature, p. 1

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/2159-8290.cd-21-0291

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 69

Metadata

Authors
Schaettler, M. O., Richters, M. M., Wang, A. Z., Skidmore, Z. L., Fisk, B., Miller, K. E., Vickery, T. L., Kim, A. H., Chicoine, M. R., Osbun, J. W., Leuthardt, E. C., Dowling, J. L., Zipfel, G. J., Dacey, R. G., Lu, H.-C., Johanns, T. M., Griffith, O. L., Mardis, E. R., Griffith, M., & Dunn, G. P.
Venue
Cancer Discovery
Published
2021-10-05
Volume
12
Issue
1
Pages
154-171
ISSN
  • 2159-8274 (ISSN-L)
  • 2159-8290
OpenAlex
W3204437300
Cited by
69
References
17
FWCI
4.64
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Characterization of the Genomic and Immunologic Diversity of Malignant Brain Tumors through Multisector Analysis. https://app.cochat.ai/papers/10.1158/2159-8290.cd-21-0291
The paper
Schaettler, M. O., Richters, M. M., Wang, A. Z., Skidmore, Z. L., Fisk, B., Miller, K. E., Vickery, T. L., Kim, A. H., Chicoine, M. R., Osbun, J. W., Leuthardt, E. C., Dowling, J. L., Zipfel, G. J., Dacey, R. G., Lu, H.-C., Johanns, T. M., Griffith, O. L., Mardis, E. R., Griffith, M., & Dunn, G. P. (2022). Characterization of the Genomic and Immunologic Diversity of Malignant Brain Tumors through Multisector Analysis. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-21-0291

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.